Display Settings:

Format

Send to:

Choose Destination
AIDS. 2009 Nov 27;23(18):2497-506. doi: 10.1097/QAD.0b013e328330ed8a.

HIV serosorting as a harm reduction strategy: evidence from Seattle, Washington.

Author information

  • 1Center for Studies in Demography and Ecology, Box 353412, University of Washington, Seattle, WA 98195, USA. scassels@u.washington.edu

Abstract

OBJECTIVE:

We sought to estimate how serosorting may affect HIV prevalence and individual risk among men who have sex with men in Seattle, Washington, and how the results vary under different assumptions of HIV testing frequency, heterogeneity in sexual behavior, and condom use.

METHODS:

We developed a deterministic mathematical model of HIV transmission dynamics. Data from the 2003 random digit dial study of men who have sex with men conducted in Seattle, Washington (n = 400) are used to parameterize the model.

RESULTS:

Predicted population-level HIV prevalence as well as an individual's risk of HIV acquisition decreases when the odds of serosorting are increased in the mathematical model. In our model based on observed levels of serosorting, we predict an HIV prevalence of 16%. In contrast, if serosorting were eliminated in the population, we predict that HIV prevalence would increase to 24.5%. However, our findings depend on rates of condom use, mean anal sex contact rates, and HIV testing in the population.

CONCLUSION:

Under realistic scenarios of sexual behavior and testing frequency for men who have sex with men in the United States, serosorting can be an effective harm reduction strategy.

Comment in

PMID:
19834319
[PubMed - indexed for MEDLINE]
PMCID:
PMC2886722
Free PMC Article

Images from this publication.See all images (4)Free text

Figure 1
Figure 2
Figure 3
Figure 4
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Write to the Help Desk